These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20370537)

  • 1. Reactivation of immobilized acetylcholinesterase-tabun complex by pralidoxime, its isomers, and homologs.
    Hoskovcová M; Halámek E; Kobliha Z; Tusarová I
    Toxicol Mech Methods; 2010 Jun; 20(5):223-6. PubMed ID: 20370537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of structural homoloques and isomers of pralidoxime in reactivation of immobilised acetylcholinesterase inhibited with sarin, cyclosarin and soman.
    Hoskovcova M; Halamek E; Kobliha Z
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():152-5. PubMed ID: 20027163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun].
    Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M
    Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
    Kuca K; Cabal J
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective bisquaternary reactivators of tabun-inhibited AChE.
    Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
    J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: an in vitro study.
    Kuca K; Jun D; Cabal J; Musilova L
    Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):25-8. PubMed ID: 17577312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy.
    Pohanka M; Karasova JZ; Musilek K; Kuca K; Kassa J
    J Appl Toxicol; 2009 Aug; 29(6):483-8. PubMed ID: 19338015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatographic preparation and kinetic analysis of interactions between tabun enantiomers and acetylcholinesterase.
    Tenberken O; Thiermann H; Worek F; Reiter G
    Toxicol Lett; 2010 Jun; 195(2-3):142-6. PubMed ID: 20347021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
    Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
    Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
    J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation steps by 2-PAM of tabun-inhibited human acetylcholinesterase: reducing the computational cost in hybrid QM/MM methods.
    da Silva Gonçalves A; França TC; Caetano MS; Ramalho TC
    J Biomol Struct Dyn; 2014; 32(2):301-7. PubMed ID: 23527625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation and aging kinetics of human acetylcholinesterase inhibited by organophosphonylcholines.
    Worek F; Thiermann H; Szinicz L
    Arch Toxicol; 2004 Apr; 78(4):212-7. PubMed ID: 14647978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivators.
    Pohanka M; Karasova JZ; Musilek K; Kuca K; Jung YS; Kassa J
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):93-7. PubMed ID: 20569082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of organophosphorus hydrolysing enzymes on obidoxime-induced reactivation of organophosphate-inhibited human acetylcholinesterase.
    Herkenhoff S; Szinicz L; Rastogi VK; Cheng TC; DeFrank JJ; Worek F
    Arch Toxicol; 2004 Jun; 78(6):338-43. PubMed ID: 14985944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties.
    Bhattacharjee AK; Kuca K; Musilek K; Gordon RK
    Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pralidoxime--the gold standard of acetylcholinesterase reactivators--reactivation in vitro efficacy.
    Kuca K; Hrabinova M; Soukup O; Tobin G; Karasova J; Pohanka M
    Bratisl Lek Listy; 2010; 111(9):502-4. PubMed ID: 21180265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conjugate of pyridine-4-aldoxime and atropine as a potential antidote against organophosphorus compounds poisoning.
    Lovrić J; Berend S; Lucić Vrdoljak A; Radić B; Katalinić M; Kovarik Z; Želježić D; Kopjar N; Rast S; Mesić M
    Acta Biochim Pol; 2011; 58(2):193-8. PubMed ID: 21666889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro reactivation of trichlorfon-inhibited butyrylcholinesterase using HI-6, obidoxime, pralidoxime and K048.
    Pohanka M; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):680-3. PubMed ID: 18825528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
    Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
    J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.